[Premedication for sonography. Enzyme-paractol in comparison with a placebo].
In a randomized double-blind comparative study involving a total of 50 patients divided into two equal groups, the effects of Enzym-Paractol and placebo on the ultrasonographic representation of internal organs in two planes--pancreatic and paraaortic--were compared. The visualizability was estimated as percentage figures, and revealed an improvement of about 15% for Enzym-Paractol as compared with placebo. With respect to undesired side effects, there was no difference between the two substances.
D000328:Adult; D000368:Aged; D000536:Aluminum Hydroxide / Q000008:administration & dosage*; D001660:Biliary Tract Diseases / Q000175:diagnosis; D002986:Clinical Trials as Topic; D004129:Dimethylpolysiloxanes; D004311:Double-Blind Method; D004338:Drug Combinations / Q000008:administration & dosage; D004798:Enzymes / Q000008:administration & dosage*; D005260:Female; D005767:Gastrointestinal Diseases / Q000175:diagnosis; D006331:Heart Diseases / Q000175:diagnosis; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis; D008107:Liver Diseases / Q000175:diagnosis; D008171:Lung Diseases / Q000175:diagnosis; D008277:Magnesium Oxide / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011292:Premedication; D012828:Silicones / Q000008:administration & dosage*; D012841:Simethicone / Q000008:administration & dosage*; D014463:Ultrasonography / Q000379:methods*
D004129:Dimethylpolysiloxanes; D004338:Drug Combinations; D004798:Enzymes; D012828:Silicones; C023473:aluminium hydroxide, magnesium oxide, simeticone drug combination; C042196:aluminum hydroxide gel, amylase, aspergillus oryzae enzyme, lipase, protease, rhizopus arrhizus enzyme, simethicone drug combination; D008277:Magnesium Oxide; D000536:Aluminum Hydroxide; D012841:Simethicone
Medikamentöse Vorbereitung zur Sonographie. Enzym-Paractol im Vergleich zu Plazebo.